Indications and uses
Helps temporarily reduce sensitivity for better control. Supports local blood flow for enhanced firmness and endurance.
Helps temporarily reduce sensitivity for better control. Supports local blood flow for enhanced firmness and endurance.
Apply a small amount (pea-sized) to the glans or desired area 5–10 minutes before activity. Allow to absorb completely before contact. Wash off after use.
Lidocaine 2.0% — Topical anesthetic (delays climax)
L-Arginine 0.1% — Nitric oxide enhancer (supports circulation)
Male desensitizing and performance enhancement gel.
Helps temporarily reduce sensitivity for better control.
Supports local blood flow for enhanced firmness and endurance.
For external use only.
Avoid contact with eyes or broken or irritated skin.
Do not use if allergic to Lidocaine or other local anesthetics.
Do not use if you have heart disease, have undergone heart stent placement, or are taking nitrate-based medications (such as nitroglycerin or isosorbide dinitrate). The vasodilating effect of L-Arginine may affect cardiovascular stability.
Stop use and consult a doctor if irritation, rash, or burning occurs.
Keep out of reach of children.
For external use only.
Avoid contact with eyes or broken or irritated skin.
Do not use if allergic to Lidocaine or other local anesthetics.
Do not use if you have heart disease, have undergone heart stent placement, or are taking nitrate-based medications (such as nitroglycerin or isosorbide dinitrate). The vasodilating effect of L-Arginine may affect cardiovascular stability.
Stop use and consult a doctor if irritation, rash, or burning occurs.
Keep out of reach of children.
Apply a small amount (pea-sized) to the glans or desired area 5–10 minutes before activity.
Allow to absorb completely before contact.
Wash off after use.
headache, flushing, indigestion, nasal congestion, dizziness, muscle pain, back pain, nausea, rash, or visual disturbances
you experience chest pain, fainting, sudden vision or hearing loss
an erection lasts longer than 4 hours (priapism). This is a medical emergency.
Not for use in pregnant or breastfeeding women
Not for use in children under 18 years
Anhydrous Alcohol, Glycerin, Propylene Glycol, Carbomer, Purified Water, Potassium Hydroxide.
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84778-103-01 | ESOKALLI Delay Performance Gel | 1.8 mL in 1 TUBE | GEL | 1.8 | 4 | |
| 84778-103-01 | ESOKALLI Delay Performance Gel | 1 in 1 BOX | GEL | 1 | 4 | |
| 84778-103-02 | ESOKALLI Delay Performance Gel | 1.8 mL in 1 TUBE | GEL | 1.8 | 4 | |
| 84778-103-02 | ESOKALLI Delay Performance Gel | 2 in 1 BOX | GEL | 2 | 4 | |
| 84778-103-03 | ESOKALLI Delay Performance Gel | 1.8 mL in 1 TUBE | GEL | 1.8 | 4 | |
| 84778-103-03 | ESOKALLI Delay Performance Gel | 3 in 1 BOX | GEL | 3 | 4 | |
| 84778-103-04 | ESOKALLI Delay Performance Gel | 1.8 mL in 1 TUBE | GEL | 1.8 | 4 | |
| 84778-103-04 | ESOKALLI Delay Performance Gel | 4 in 1 BOX | GEL | 4 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 84778-103 | 84778-103-01, 84778-103-02, 84778-103-03, 84778-103-04 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| POTASSIUM HYDROXIDE | WZH3C48M4T | IACT |
| LIDOCAINE | 98PI200987 | ACTIB |
| ARGININE | 94ZLA3W45F | ACTIB |
| GLYCERIN | PDC6A3C0OX | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 42b2f99b-7bdf-cc56-e063-6294a90a27de | 41f89c38-32c2-f2fa-e063-6294a90ad6bd | 2025-11-03 | Warnings | 42b2f99b-7bdf-cc56-e063-6294a90a27de 41f89c38-32c2-f2fa-e063-6294a90ad6bd |
Adverse event summaries are temporarily unavailable. Other product information remains available.